Scarica l'app Stockscreener
5.6185
1.08%
0.0385
Precedente Chiudi:
$5.58
Aprire:
$5.55
Volume 24 ore:
776
Relative Volume:
0.01
Capitalizzazione di mercato:
$67.43M
Reddito:
$59.14M
Utile/perdita netta:
$-51.52M
Rapporto P/E:
-1.2807
EPS:
-4.387
Flusso di cassa netto:
$-11.88M
1 W Prestazione:
-7.69%
1M Prestazione:
-52.45%
6M Prestazione:
-54.33%
1 anno Prestazione:
-60.11%
Intervallo 1D:
$5.55
$5.645
Intervallo di 1 settimana:
$5.51
$6.20
Portata 52W:
$5.51
$14.31
Lensar Inc Stock (LNSR) Company Profile
Nome
Lensar Inc
Settore
Industria
Telefono
888-536-7271
Indirizzo
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
5.645 | 66.65M | 59.14M | -51.52M | -11.88M | -4.387 |
ABT
Abbott Laboratories
|
105.08 | 182.16B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.99 | 125.39B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.75 | 112.84B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
70.27 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.32 | 48.01B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-02-24 | Iniziato | SVB Leerink | Outperform |
Lensar Inc Borsa (LNSR) Ultime notizie
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
LENSAR, Inc. Hits New 52-Week Low at $5.52 Amidst Market Struggles - Markets Mojo
Alcon Inc stock faces uncertainty as Lensar merger collapses, pivots to organic growth strategy - AD HOC NEWS
LENSAR Inc stock plunges as Alcon terminates merger over FTC antitrust block - AD HOC NEWS
LENSAR Inc stock faces prolonged uncertainty as Alcon merger awaits FTC approval amid regulatory del - AD HOC NEWS
LENSAR Inc stock faces uncertainty as Alcon merger awaits final regulatory approval amid pending FTC - AD HOC NEWS
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.82 - Markets Mojo
Alcon Inc stock faces uncertainty as Lensar merger collapses, prompting strategic pivot to core eye - AD HOC NEWS
Behavioral Patterns of LNSR and Institutional Flows - Stock Traders Daily
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.83 - Markets Mojo
Lensar Files for Chapter 11 Bankruptcy Protection | RapidScan | Jan 2017 - Photonics Spectra
LENSAR Inc Stock Faces Uncertainty Ahead of Key Earnings as Laser Tech Sector Heats Up - AD HOC NEWS
LENSAR stock plunges—Alcon scraps merger after prolonged regulatory review - MSN
S P Trends: Can LENSAR Inc reach all time highs this yearMarket Movers & Risk Managed Investment Signals - baoquankhu1.vn
Alcon Inc stock faces pressure amid terminated LENSAR merger and market downturn - AD HOC NEWS
LENSAR, Inc. Hits New 52-Week Low at $6.55 Amid Market Struggles - Markets Mojo
LENSAR, Inc. Hits New 52-Week Low at $5.98 Amidst Declining Performance - Markets Mojo
Alcon, LENSAR abandon proposed merger amidst FTC pushback - Ophthalmology Times
Lensar Stock Loses 48% This Week Despite BTIG Upgrade To Buy - TIKR.com
LENSAR (LNSR) CFO exercises options, holds 175,959 shares - Stock Titan
Lensar agrees to terminate sale to Alcon - MSN
Systane Eye Drops Lead Alcon's Shift to Organic Growth After Lensar Deal Collapse - AD HOC NEWS
Alcon and Lensar terminate proposed merger after FTC pressure - Eyes On Eyecare
Factset, Lensar, Starbucks - TradingView
LENSAR, Inc. Stock Plummets to New 52-Week Low of $6.70 - Markets Mojo
LENSAR Inc - Reuters
Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Assertio Therapeutics (ASRT) and LENSAR (LNSR) - The Globe and Mail
Aug Gainers: Whats the MACD signal for LENSAR IncMarket Risk Analysis & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC) - Seeking Alpha
This Block Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Wednesday - Benzinga
LNSR Stock Upgraded to Buy by BTIG Analyst Ryan Zimmerman | LNSR - GuruFocus
LNSR | LENSAR, Inc. Common Stock Analyst Forecasts - Quiver Quantitative
BTIG upgrades LENSAR (LNSR) - MSN
Alcon and Lensar Agree to Terminate Merger Agreement - VisionMonday.com
LENSAR cancels Alcon merger agreement, prepares strategic update - MSN
BTIG upgrades Lensar stock rating to buy after Alcon deal ends - Investing.com India
ACQUISITIONS & MERGERS NEWS: FTC successfully blocks Alcon-LENSAR merger in cataract surgery laser market - VitalLaw.com
BTIG upgrades Lensar stock rating to buy after Alcon deal ends By Investing.com - Investing.com South Africa
Alcon Drops $430M Lensar Deal Under Pressure From FTC - Law360
Alcon abandons effort to purchase LENSAR after FTC scrutiny - MedTech Dive
LENSAR Terminates Merger Agreement with Alcon Following FTC Challenge, Retains $10M Deposit and Announces Strategic Update - Minichart
Lensar Share Slide on Terminated Merger Deal With Alcon - marketscreener.com
Alcon, LENSAR terminate merger agreement after US FTC opposition - MLex
Alcon, LENSAR Halt Merger Deal Amid FTC Scrutiny - Medical Product Outsourcing
BYND And LNSR Set The Tone Tuesday - TradingView
US FTC stops proposed merger of Alcon, LENSAR - MLex
US FTC Says It Stops Proposed Merger Of Cataract-Surgery Device Makers Lensar And Alcon - TradingView
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Ends Alcon Merger, Plans Strategic Update - TipRanks
Lensar and Alcon Sign Termination Agreement; Lensar Retains $10 Million Deposit - TradingView
Lensar Inc Azioni (LNSR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):